Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
Clinical trial NCT03160885 · COMPLETED
Trial details
- NCT number
- NCT03160885
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2018-09-04
- Enrollment
- 794
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.